Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
2026 · 3rd Quarter (July 1 - Sep 30)
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY)
Filed by KOUNTOUPES DENHAM CARR & REID, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 6, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Filing UUID
- e0aa07db-087a-4319-a17e-54fba417867a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Issues related to the tax treatment of charitable contributions.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.